Roxane Laboratories, Inc. announced the approval of their Abbreviated New Drug Application for Protriptyline HCl Tablets, USP, 5mg and 10mg. The product is available in bottles of 100 tablets for immediate shipment to wholesalers and pharmacies nationwide.

 

Roxane Laboratories' Protriptyline HCl Tablets, USP are AB rated to VIVACTIL® (protriptyline HCl). Annual sales of VIVACTIL® (protriptyline HCl) Tablets are approximately $11.3 Million(1). Roxane Laboratories, Inc., is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.